by In2Pharma | Dec 6, 2017 | News
Luxembourg As from 9 February 2019, the Falsified Medicines Directive (FMD) will apply. Based on this, the Luxembourg National Medicines Verification Organisation (LMVO) will implement a Luxembourg verification system in cooperation with the Belgian National Medicines...
by In2Pharma | Sep 27, 2017 | News
Belgium Riziv/Inami, FAMHP and BeMVO published together a joint declaration concerning the implementation of the Falsified Medicines Directive (FMD) in Belgium. In this joint declaration, several arrangements have been laid down to optimize the cooperation between the...
by In2Pharma | Sep 12, 2017 | News
FAMHP Recently, FAMHP published guidelines as well as Q&A documents related to the Falsified Medicines Directive. No later than 9 February 2019, safety features as imposed by the Falsified Medicines Directive 2011/62/EU of the European Parliament and of the...
by In2Pharma | Jun 21, 2017 | News
BeMVO Every Marketing Authorization Holder (MAH) that distributes medicinal products that fall within the Belgian scope of the Falsified Medicines Directive (FMD) by February 9th 2019 must register to and contract with the Belgian Medicines Verification Organisation...
